0000899243-21-017837.txt : 20210503
0000899243-21-017837.hdr.sgml : 20210503
20210503190103
ACCESSION NUMBER: 0000899243-21-017837
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210429
FILED AS OF DATE: 20210503
DATE AS OF CHANGE: 20210503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ho Tony W
CENTRAL INDEX KEY: 0001713637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 21885230
MAIL ADDRESS:
STREET 1: CRISPR THERAPEUTICS AG
STREET 2: 610 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-29
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001713637
Ho Tony W
C/O ITEOS THERAPEUTICS, INC.
139 MAIN STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
24.11
2021-04-29
4
A
0
33217
0.00
A
2031-04-29
Common Stock
33217
0
D
This stock option shall vest over 3 years, with 1/3 vesting on April 29, 2022, and thereafter in equal monthly installments over the next 24 months subject to the Reporting Person's continued service as a director through the applicable vesting date.
/s/ Michel Detheux, as Attorney-in-Fact
2021-05-03